About us
The diabetes information portal diabinfo.de and its sub-portals Preventing diabetes, Living with diabetes and Information for diabetes professionals are a collaborative effort by Helmholtz Munich, the German Diabetes Center in Düsseldorf, and the German Center for Diabetes Research. The portal was initiated by the Federal Center for Health Education (BZgA). Funding comes from the BZgA, the Federal Ministry of Health (BMG), and the Federal Ministry of Education and Research (BMBF).
diabinfo.de offers up-to-date, neutral, and scientifically validated online information covering all forms of diabetes mellitus and diabetes prevention. Findings from the fields of medicine and diabetes research are presented in an easily comprehensible manner. diabinfo.de is also involved as an exhibitor and organizer in public information events. Experts give lectures presenting the latest scientific findings. Patients, relatives, and interested parties also have the opportunity to contact experts directly and pose individual questions.
All content on diabinfo.de serves to inform the public. All content has been diligently researched and is scientifically sound. However, the information cannot replace consultation with a physician or other qualified specialist personnel. diabinfo.de does not provide advisory services or give recommendations. The listed points of contact, medical facilities, etc. are not exhaustive and their order is purely coincidental and should not be viewed as a classification. Personal statements and views contained in the published testimonials are labeled as such.
diabinfo.de is also involved with the program Reliable Health Information (Verlässliches Gesundheitswissen) (Link in German) from the German Network for Health Literacy (Deutsches Netzwerk Gesundheitskompetenz – DNGK).
Video: diabinfo – Who we are
English video subtitles available.
Helmholtz Munich is the German Research Center for Health and Environment. It explores the development of common diseases in the context of environmental factors, lifestyle, and individual genetic predisposition, while also developing innovative approaches for prevention, diagnosis, and therapy. The center particularly focuses on researching diabetes mellitus, allergies, and chronic lung diseases. Diabetes is viewed as a system where genetics and environmental influences, especially lifestyle, converge. The center works closely with the two Munich universities to discover new therapeutic, preventive and diagnostic approaches. The existing expertise is consolidated in translational research and clinical projects, molecular mechanisms of diabetes development, as well as systems biology and modeling. As a research institution of the federal government and the Free State of Bavaria, Helmholtz Munich is a member of the Helmholtz Association of German Research Centers and a partner in the German Center for Diabetes Research (DZD).
The German Diabetes Center (DDZ) is an interdisciplinary research institution that connects molecular and cell biology basic research with clinical and epidemiological research approaches. The DDZ's task is to develop new approaches for the prevention, early detection, and diagnosis of diabetes mellitus. Furthermore, it aims to improve the therapy of diabetes and the treatment of its complications, as well as enhance epidemiological data. Extensive clinical studies, for example, investigate how diabetes changes in humans over time and how the course of the disease can be influenced. The DDZ is the German reference center of the Leibniz Association for diabetes and a partner in the German Center for Diabetes Research (DZD). In this role, the DDZ serves as a point of contact for stakeholders in the healthcare sector.
The German Center for Diabetes Research (DZD) is a national health research center where 10 diabetes research institutions and university clinics collaborate nationwide. Using modern biomedical technologies, new methods, and research approaches, the DZD significantly contributes to understanding the origin of the disease, developing evidence-based prevention, preventive and healthcare research, and individualized, causal therapies. Various research groups, including experts from basic research, epidemiology, clinical application, and medical professionals, examine the risk, development, progression, and treatment options for diabetes from different perspectives. An important focus is also the dissemination of scientific results to the public and professionals, as well as the incorporation of new treatment methods into guidelines.
Prof. Dr. Peter Achenbach, Helmholtz Munich, DZD
Dr. Robin Assfalg, Helmholtz Munich, DZD
Dr. Ulrike Becker, Gesundheitspraxis Bonn
Prof. Dr. Johannes Beckers, Helmholtz Munich, DZD
Prof. Dr. Thomas Beikler, Universitätsklinikum Hamburg-Eppendorf
Faize Berger, Arbeitsgemeinschaft Diabetes und Migranten der Deutschen Diabetes Gesellschaft
Prof. Dr. Andreas Birkenfeld, Helmholtz Munich, Universitätsklinikum Tübingen, DZD
Dr. Kálmán Bódis, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Kathrin Boehm, Diabetes-Klinik Bad Mergentheim, DZD
Dr. Gidon Bönhof, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
PD Dr. Volker Burkart, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Carolin Daniel, Helmholtz Munich, DZD
R.A. Oliver Ebert, REK Rechtsanwälte, Stuttgart, Balingen
Prof. Dr. Kristina Friedland, Johannes Gutenberg-Universität, Mainz
Prof. Dr. Andreas Fritsche, Helmholtz Munich, Universitätsklinikum Tübingen, DZD
PD Dr. Martin Füchtenbusch, Forschergruppe Diabetes e.V. am Helmholtz Munich, Diabeteszentrum am Marienplatz, München
Prof. Dr. Baptist Gallwitz, Universitätsklinikum Tübingen, DZD
Dr. Sofiya Gancheva, Universitätsklinikum Düsseldorf
Dr. Christina Gar, Ludwig-Maximilian-Universität München, DZD
Prof. Dr. Rainer Guthoff, Universitätsklinikum Düsseldorf
Prof. Dr. Martin Halle, Technische Universität München, DZD
Dr. Nicola Haller, Verband der Diabetes-Beratungs- und Schulungsberufe in Deutschland e. V.
Dr. Stefanie Haschka, Technische Universität München
Prof. Dr. Hans Hauner, Technische Universität München, Deutsche Diabetes Stiftung, DZD
Dr. Verena Heinicke, Technische Universität München
Prof. Dr. Martin Heni, Universitätsklinikum Ulm
Prof. Dr. Christian Herder, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Stephan Herzig, Helmholtz Munich, DZD
Prof. Dr. Christina Holzapfel, Hochschule Fulda, Technische Universität München
Prof. Dr. Martin Hrabě de Angelis, Helmholtz Munich, DZD
Dr. Elisabeth Huber, Helmholtz Munich
PD Dr. Sandra Hummel, Helmholtz Munich, DZD
Prof. Dr. Michael Hummel, Forschergruppe Diabetes e.V. am Helmholtz Munich, Diabetologische Schwerpunktpraxis, Rosenheim
Maximilian Huttasch, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Dr. Andrea Icks, Heinrich-Heine-Universität Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Karin Jandeleit-Dahm, Monash University, Melbourne, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Christine Joisten, Sporthochschule Köln
Dr. Stefan Kabisch, Charité Berlin (Studienzentrum DIfE, DZD)
Dr. Sabine Kahl, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Clemens Kamrath, Universitätsklinikum Giessen
Dr. Yanislava Karusheva, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Maximilian Kleinert, Deutsches Institut für Ernährungsforschung, Potsdam, DZD
Theresa Kössler, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Manfred Krüger, Kommission Apotheker in der Diabetologie, BAK/DDG
Dr. Michael Kruse, Praxis für Allgemeinmedizin, Minden
PD Dr. Stephanie Kullmann, Helmholtz Munich, Universitätsklinikum Tübingen, DZD
Prof. Dr. Bernhard Kulzer, Diabetes-Klinik Bad Mergentheim, DZD
Prof. Dr. Oliver Kuß, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Rüdiger Landgraf, Deutsche Diabetes Stiftung, München
PD Dr. Andreas Lechner, Hausarztpraxis in München Nymphenburg, Ludwig-Maximilian-Universität München, DZD
Prof. Dr. Heiko Lickert, Helmholtz Munich, DZD
Maria Lipinski, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Barbara Ludwig, Universitätsklinikum Carl Gustav Carus, Dresden, DZD
Dr. Berthold Maier, Diabetes-Klinik Bad Mergentheim, DZD
Dr. Eric Martin, Hubertus-Apotheke, Marktheidenfeld
Prof. Dr. Sebastian Meyhöfer, Uniklinikum Lübeck, DZD
Clara Möser, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Hansjörg Mühlen, Diabetologikum Duisburg
PD Dr. Timo Müller, Helmholtz Munich, DZD
Prof. Dr. Karsten Müssig, Franziskus-Hospital Harderberg, Georgsmarienhütte
Dr. Kalliopi Pafili, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Rainer Paust, Elisabeth-Krankenhaus Essen
Prof. Dr. Dominik Pesta, Deutsches Zentrum für Luft- und Raumfahrt, Köln, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Andreas Pfeiffer, Charité Berlin
Dr. Johanna Pfeil, Universitätsklinikum Greifswald, Brunnen-Apotheke, Kirchheim bei München
Prof. Dr. Paul Pfluger, Helmholtz Munich, DZD
Katja Prax, Krankenhausapotheke der München Klinik gGmbH
Dr. Nicole Prinz, Universität Ulm
Prof. Dr. Wolfgang Rathmann, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Katja Renner, Apotheke am MDZ, Heinsberg
Dr. Kurt Rinnert, Betriebsärztlicher Dienst der Stadt Köln
Prof. Dr. Michael Roden, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Joachim Rosenbauer, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Theresia Sarabhai, Universitätsklinikum Düsseldorf
Dr. Sebahat Sat, MVZ DaVita Rhein-Ruhr, Düsseldorf
Dr. Martin Scherm, Helmholtz Munich, Ludwig-Maximilian-Universität München
Dr. Helmut Schlager, Wissenschaftliches Institut für Prävention im Gesundheitswesen der Bayerischen Landesapothekerkammer, München
PD Dr. Sabrina Schlesinger, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Karin Schmiedel, Kur-Apotheke, Bad Windsheim
Dr. Alexandra Schneider, Helmholtz Munich, DZD
Dr. Martin Schön, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Annette Schürmann, Deutsches Institut für Ernährungsforschung, Potsdam, DZD
Prof. Dr. Peter Schwarz, Universitätsklinikum Dresden, DZD
Dr. Esther Seidel-Jacobs, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Norbert Stefan, Helmholtz Munich, Universitätsklinikum Tübingen, DZD
Dr. Alexander Strom, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Edyta Szczerba, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Julia Szendrödi, Universitätsklinikum Heidelberg, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Thaddäus Tönnies, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Andreas Vosseler M.A., Universitätsklinikum Tübingen, DZD
Prof. Dr. Robert Wagner, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Katharina Warncke, München Klinik Schwabing
Dr. Katharina Weber, Christian-Albrechts-Universität zu Kiel
Prof. Dr. Cora Weigert, Helmholtz Munich, Universitätsklinikum Tübingen, DZD
Andreas Weiss, Helmholtz Munich, DZD
Iryna Yurchenko, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Oana Patricia Zaharia, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Prof. Dr. Anette-Gabriele Ziegler, Helmholtz Munich, DZD
Prof. Dr. Dan Ziegler, Universitätsklinikum Düsseldorf, Deutsches Diabetes-Zentrum, Düsseldorf, DZD
Dr. Elric Zweck, Universitätsklinikum Düsseldorf
diabinfo.de generally does not publish advertisements on its website.
Products, brands, and other commercial offers are only mentioned by name if there is no similar product or offer on the market. diabinfo.de only provides recommendations for individual active substance if they adhere to qualitative guidelines and their efficacy is confirmed in reputable sources.
No sponsoring takes place.
As of: 26.07.2023